BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    66.
    发明公开
    BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF 有权
    苯并咪唑衍生物和它们的药学上可接受的盐

    公开(公告)号:EP0974589A4

    公开(公告)日:2001-07-25

    申请号:EP98951721

    申请日:1998-11-06

    摘要: Compounds represented by general formula (I) and having both an IL-4 production inhibitory activity and a PDE(IV) inhibitory activity; a medicinal composition comprising an effective amount of any of the compounds and a pharmaceutical carrier; a remedy or preventive for acute and chronic inflammatory diseases; and an antiallergic agent or antiphlogistic agent: wherein A is a triazole group; R1 and R2 are the same or different and each is an alicyclic hydrocarbon group or an aliphatic or alicyclic hydrocarbon group optionally having an aromatic hydrocarbon group; R3 is hydrogen or a substituent; and R4 is hydrogen or a group protecting the nitrogen atom. Also provided are methods of using the compounds represented by formula (I) for the production of the medicinal composition, the remedy or preventive for acute and chronic inflammatory diseases, and the antiallergic agent or antiphlogistic agent; and a method for the therapy and/or prevention of acute and chronic inflammatory diseases.

    CATHEPSIN-L-SPECIFIC INHIBITOR POLYPEPTIDE
    70.
    发明授权
    CATHEPSIN-L-SPECIFIC INHIBITOR POLYPEPTIDE 失效
    抑制肽特异性组织蛋白酶L

    公开(公告)号:EP0679659B1

    公开(公告)日:1999-04-14

    申请号:EP94931695.4

    申请日:1994-11-08

    IPC分类号: C07K14/81 A61K38/57

    CPC分类号: C07K14/8139 A61K38/00

    摘要: A polypeptide having the amino acid sequence represented by the following SEQ ID NO: 1, and a cathepsin-L-specific inhibitor and an osteoporosis remedy each containing the polypeptide as the active ingredient. The polypeptide has such potent cathepsin-L-specific inhibitor and bone resorption inhibitor activities that it is useful for treating osteoporoses, in particular, senile osteoporosis.